Journal profile · ONCOLOGY
ESMO Gastrointestinal Oncology
ISSN 2949-8198
ESMO Gastrointestinal Oncology: impact factor 1.7 (journal website); fully open access; APC about USD 3,480; review about 85 days (submission to acceptance, publisher); 141 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, ESMO Gastrointestinal Oncology's largest topics are Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Esophageal Cancer Research and Treatment, together about 29.9% of its articles. Its main subfields are Oncology and Surgery. (generated from OpenAlex topic counts and CAS ranking data)
ESMO Gastrointestinal Oncology, the journal of the European Society for Medical Oncology, is dedicated to publishing high-quality research and commenting on all aspects of the diagnosis, treatment and understanding of gastrointestinal cancers.The journal aims to publish experimental, translational, diagnostic and therapeutic research. Specific areas of interest include but are not limited to gastrointestinal cancer biology and epidemiology, prevention and early detection, advances in molecular, genetic and imaging diagnostics, therapeutic studies from pre-clinical to clinical (phase I-IV) with a focus on targeted and immunotherapy, translational research, patient-oriented studies, psychosocial aspects of disease, treatment of long-term morbidity and survivorship, palliative and supportive care, novel methods and clinical protocols. The journal welcomes original articles, reviews, mini reviews, editorials, research methods and clinical trial summaries, and correspondence. In addition, it provides in-depth commentaries from leading experts and engages in active debate on important topics via its pro and con discussion section.ESMO Gastrointestinal Oncology is committed to providing swift review and publication supported by our team of experienced international experts and key opinion leaders. The journal will provide essential reading for cancer researchers, clinician-scientists, clinicians with a focus gastrointestinal cancer, patient advocates and all health care professionals with a specific interest in gastrointestinal cancers. The journal rapidly disseminates the best innovative clinical and translational research and aims to improve the quality of education, prevention, diagnosis, treatment and patient care worldwide.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Irit Ben-AharonPublisher website
Editorial board by country: 3 in mainland China (about 6%); most named United States 7, Germany 5, Mainland China 3, Hong Kong, China 3, Japan 3 (54 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Gastric Cancer Management and OutcomesMedicine11.6%
- Colorectal Cancer Treatments and StudiesMedicine9.4%
- Esophageal Cancer Research and TreatmentMedicine8.9%
- Pancreatic and Hepatic Oncology ResearchMedicine7.2%
- Cancer Immunotherapy and BiomarkersMedicine6%
- Cholangiocarcinoma and Gallbladder Cancer StudiesMedicine6%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology4.8%
- Colorectal and Anal CarcinomasMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ScopusPubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.7Publisher website ·
- CiteScore (publisher)
- 0.9Publisher website ·
- h-index
- 9OpenAlex ·
- i10-index
- 9OpenAlex ·
- 2-year mean citedness
- 1.39OpenAlex ·
- Self-citation rate
- 11.8%LetPub ·
- Share of gold OA articles
- 98.84%LetPub ·
Volume
- Articles per year
- 104LetPub ·
Articles by year OpenAlex count · 336 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 108 | 108 | 15 |
| 2025 | 141 | 141 | 207 |
| 2024 | 70 | 70 | 223 |
| 2023 | 17 | 17 | 51 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
85 dayssubmission to acceptance
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Submission to acceptance
- 85 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,480 | Yes | CC BY-NC-ND | |
| OpenAlex | USD 3,170 / EUR 2,890 / GBP 2,540 / JPY 393,180 | — | — | |
| Publisher website | USD 3,480 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
Publisher websiteWhat to prepare1 items from the author guidelines
- Not considered
- Papers including results or preliminary data
Article types accepted14, with length limits
- commentarysals for future avenues of exploration. Commentaries are generally commissioned by the Editors and should be a maximum of 1,500 words and have a maximum of ten …main text ≤ 1,500 words
- correspondenceOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…Length not stated
- editorialOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…main text ≤ 1,500 words
- letterOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…Length not stated
- letters to the editorOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…Length not stated
- meta-analysisOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…Length not stated
- mini reviewOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…main text ≤ 2,000 words
- narrative reviewOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…Length not stated
- original articleOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…main text ≤ 3,500 words
- original researchOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…Length not stated
- reviewOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…Length not stated
- review articleOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…main text ≤ 4,000 words
- short communicationA short communication should include a concise report of a unique original study or case series, reported for the first time. This could also include negative s…main text ≤ 200 words · abstract ≤ 200 words · references ≤ 4
- systematic reviewOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
The below guidance only refers to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process.Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. AI and AI-assisted technologies should not be used t…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Source ↗Publisher website ·- Conflicts of interest Declaration of Potential Conflicts of Interest
Any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications or opinions stated - including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition - should…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.
Source ↗Publisher website ·- Open access Open Access
Article Publishing Charge (APC): USD 3,480 (excluding taxes). Review this journal’s open access policy.
Source ↗Publisher website ·- Peer review Peer review
This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Preprints Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- ISSN
- 2949-8198
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
FAQ
Frequently asked questions about ESMO Gastrointestinal Oncology
What is the impact factor of ESMO Gastrointestinal Oncology?
The journal's website gives an impact factor of 1.7; this is the journal's own figure, as LetPub lists none for it; h-index 9.
How long does peer review take at ESMO Gastrointestinal Oncology?
The publisher reports about 85 days (submission to acceptance). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of ESMO Gastrointestinal Oncology based?
Of the 54 board members whose country the journal's board page names, 3 (about 6%) are in mainland China; the countries named most often are United States (7), Germany (5) and Mainland China (3). Counted from the institutions listed on the board page; for reference only.
Which databases index ESMO Gastrointestinal Oncology?
According to LetPub and DOAJ records, ESMO Gastrointestinal Oncology is indexed in ESCI and DOAJ. The journal's website also lists Scopus and PubMed; that list has not been checked against each database.
Is ESMO Gastrointestinal Oncology open access, and what is the APC?
ESMO Gastrointestinal Oncology is a fully open-access journal. APC about USD 3,480.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .